Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (5) , 595-601
- https://doi.org/10.1016/j.amjcard.2004.05.022
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of nesiritide versus milrinone in the treatment of acute decompensated heart failure.American Journal of Health-System Pharmacy, 2003
- Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT studyAmerican Heart Journal, 2002
- Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart FailureA Randomized Controlled TrialJAMA, 2002
- Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failureJournal Of Hypertension, 2001
- Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapyThe American Journal of Cardiology, 2001
- Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart FailureNew England Journal of Medicine, 2000
- Cardiac fibrosis in mice lacking brain natriuretic peptideProceedings of the National Academy of Sciences, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)American Heart Journal, 1999
- Brain Natriuretic Peptide: Effect on Left Ventricular Filling Patterns in Healthy SubjectsClinical Science, 1995